| Literature DB >> 35965045 |
Aabida Saferali1, Craig P Hersh2.
Abstract
Genome-wide association studies (GWAS) of asthma and chronic obstructive pulmonary disease (COPD) with ever-increasing sample sizes have found multiple genetic loci associated with either disease. However, there are few intersecting loci between asthma and COPD. GWAS specifically focused on asthma-COPD overlap (ACO) have been limited by smaller sample sizes and the lack of a consistent definition of ACO that has also hampered clinical and epidemiologic studies. Other genomic techniques, such as gene expression profiling, are feasible with smaller sample sizes. Genetic analyses of objective measures of airway reactivity and allergy/T2 inflammation biomarkers in COPD studies may be another strategy to overcome limitations in ACO definitions.Entities:
Keywords: Asthma; Chronic obstructive pulmonary disease; Genome-wide association study; RNA-Sequencing; Single-nucleotide polymorphism; Whole-genome sequencing
Mesh:
Year: 2022 PMID: 35965045 PMCID: PMC9379112 DOI: 10.1016/j.iac.2022.03.003
Source DB: PubMed Journal: Immunol Allergy Clin North Am ISSN: 0889-8561 Impact factor: 3.152